Related Experiment Videos
Ipratropium bromide and airways function in wheezy infants
Insights
Ipratropium bromide improved central airway function in wheezy infants but did not affect peripheral airway function. This suggests anticholinergic drugs primarily benefit larger airways, potentially explaining their limited use in acute bronchiolitis.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Respiratory Medicine
Background:
- Wheezing is common in infants, often linked to airway inflammation.
- Anticholinergic medications are used for respiratory conditions, but their efficacy in infants is debated.
Purpose of the Study:
- To investigate the airway response of infants with chronic or recurrent wheezing to nebulized ipratropium bromide.
- To differentiate the effects on central and peripheral airways.
Main Methods:
- 17 infants (4-15 months) with wheezing received nebulized ipratropium bromide.
- Peripheral airway response measured by Vmax FRC (maximum flow at functional residual capacity).
- Central and upper airway response measured by specific airways resistance.
Main Results:
- Ipratropium bromide significantly reduced specific airways resistance, indicating improved central and upper airway function.
- No significant change was observed in Vmax FRC, suggesting no effect on peripheral airway function.
- The drug's effects were localized to larger airways, similar to findings in older individuals.
Conclusions:
- Nebulized ipratropium bromide improves central and upper airway function in wheezy infants.
- Peripheral airway function remains unaffected, indicating a limited role for anticholinergics in conditions predominantly affecting small airways, such as acute bronchiolitis.
Abstract:
The airway response to nebulised ipratropium bromide was studied in 17 chronically or recurrently wheezy infants aged 4-15 months. The peripheral airway response was assessed by the change in maximum flow at functional residual capacity (Vmax FRC) and the upper and central airway response by the change in specific airways resistance. The significant reduction in specific airways resistance after treatment with ipratropium bromide signified an improvement in central and upper airway function. No change was found, however, in Vmax FRC and hence in peripheral airway function. It seems that, as in older subjects, inhaled antimuscarinic, anticholinergic drugs have their maximum effect on the large airways, and this may explain their lack of effect in the management of acute bronchiolitis.